Centre for Quantum Computer Technology. Development of a quantum computer (QC) for massively parallel computing is one of the major challenges in science and engineering this century. Since 2000 the Centre has achieved two major breakthroughs in this field: constructing the key functional element of a silicon solid-state QC; and co-inventing a scheme for efficient linear optics QC. The proposed CoE aims to align these two nationally co-ordinated research programs with the world's existing comput ....Centre for Quantum Computer Technology. Development of a quantum computer (QC) for massively parallel computing is one of the major challenges in science and engineering this century. Since 2000 the Centre has achieved two major breakthroughs in this field: constructing the key functional element of a silicon solid-state QC; and co-inventing a scheme for efficient linear optics QC. The proposed CoE aims to align these two nationally co-ordinated research programs with the world's existing computer and IT industries to realise a fault-tolerant multiple qubit quantum processor with integrated control and qubit chips, and develop a scaleable optical quantum processor providing significant economic benefit to Australia.Read moreRead less
Inhibition of pro-inflammatory cytokine secretion- A new route to therapeutics of chronic inflammatory disease. Chronic inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease, affect millions of people leading to considerable suffering, economic loss and premature death. Anti-TNF treatments have recently shown success in the treatment of rheumatoid arthritis, inflammatory bowel disease and other conditions, however, a substantial number of patients (~50%) do not re ....Inhibition of pro-inflammatory cytokine secretion- A new route to therapeutics of chronic inflammatory disease. Chronic inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease, affect millions of people leading to considerable suffering, economic loss and premature death. Anti-TNF treatments have recently shown success in the treatment of rheumatoid arthritis, inflammatory bowel disease and other conditions, however, a substantial number of patients (~50%) do not respond to the current TNF treatments. Improved anti-TNF strategies would provide enhanced health outcomes and welcome relief to many Australians. In addition, the economic benefit of the TNF market is very substantial. Therefore the potential impact of this research is very high both for health care and economical potential.Read moreRead less